Extracellular regulation of transforming growth factor β and bone morphogenetic protein signaling in bone

Annals of the New York Academy of Sciences

Volumn 1192, Issue , 2010, Pages 253-256

  Nistala, Harikiran ^a   Lee Arteaga, Sui ^a   Siciliano, Gabriella ^a   Smaldone, Silvia ^a   Ramirez, Francesco ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

BMP; Fibrillin microfibrils; Marfan syndrome; Osteoblast differentiation; Osteopenia; TGF

Indexed keywords

BONE MORPHOGENETIC PROTEIN; FIBRILLIN; GROWTH FACTOR; OSTEOGENIC PROTEIN 1; TRANSCRIPTION FACTOR RUNX2; TRANSFORMING GROWTH FACTOR BETA;

ARACHNODACTYLY; BIOENGINEERING; BONE DEVELOPMENT; BONE GROWTH; BONE MINERALIZATION; BONE REMODELING; CONFERENCE PAPER; CYTOKINE PRODUCTION; ELASTIC FIBER; EXTRACELLULAR SPACE; FIBER; FRACTURE; GENE MUTATION; HUMAN; MARFAN SYNDROME; MESENCHYMAL STEM CELL; MODULATION; MOLECULAR MECHANICS; NONHUMAN; OSTEOBLAST; OSTEOCLAST; OSTEOPOROSIS; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

EID: 77950641313     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2009.05350.x     Document Type: Conference Paper

References (28)

1. Ramirez, F. & D. Rifkin. 2003. Cell signaling events: a view from the matrix. Matrix Biol. 22: 101-107.
2. Ramirez, F. & D.B. Rifkin. 2009. Extracellular microfibrils: contextual platforms for TGFβ and BMP signaling. Curr. Opin. Cell Biol. 21: 616-622.
3. Ramirez, F. & L.Y. Sakai. 2009. Biogenesis and function of fibrillin assemblies. Cell and Tissue Res. [Epub ahead of print].
4. Zhang, H.,W. Hu, F. Ramirez. 1995. Developmental expression of fibrillin genes suggests heterogeneity of extracellular microfibrils. J. Cell Biol. 129: 1165-1176.
5. Kitahama, S., M.A. Gibson, G. Hatzinikolas, et al. 2000. Expression of fibrillins and other microfibril-associated proteins in human bone and osteoblast-like cells. Bone 27: 61-67.
6. Quondamatteo, F., D.P. Reinhardt, N.L. Charbonneau, et al. 2002. Fibrillin-1 and fibrillin-2 in human embryonic and early fetal development. Matrix Biol. 21: 637-646.
7. Charbonneau,N.L., R.N. Ono, G.M. Corson, et al. 2004. Fine tuning of growth factor signals depends on fibrillin microfibril networks. Birth Defects Res. C Embryo Today 72: 37-50.
8. Roman-Roman, S., T. Garcia, A. Jackson, et al. 2003. Identification of genes regulated during osteoblastic differentiation by genome-wide expression analysis of mouse calvaria primary osteoblasts in vitro. Bone 32: 474-482.
9. Ulloa-Montoya, F., B.L. Kidder, K.A. Pauwelyn, et al. 2007. Comparative trascriptome analysis of embryonic and adult stem cells with extended and limited differentiation capacity. Genome Biol. 8: R163.
10. Huang, Z., E.R. Nelson, R.L. Smith & S.B. Goodman. 2007. The sequential expression profiles of growth factors from osteoprogenitors to osteoblasts in vitro. Tissue Eng. 13: 2311-2320.
11. Ramirez, F.& H.C. Dietz. 2009. Extracellular microfibrils in vertebrate development and disease processes. J. Biol. Chem. 284: 14677-14681.
12. Arteaga-Solis, E., B. Gayraud, S.Y. Lee, et al. 2001. Regulation of limb patterning by extracellular microfibrils. J. Cell Biol. 154: 275-281.
13. Carta, L., L. Pereira, E. Arteaga-Solis, et al. 2006. Fibrillins 1 and 2 perform partially overlapping functions during aortic development. J. Biol. Chem. 281: 8016-8023.
14. Sengle, G., N.L. Charbonneau, R.N. Ono, et al. 2008. Targeting of bone morphogenetic protein growth factor complexes to fibrillin. J. Biol. Chem. 283: 13874-13888.
15. Sengle, G., R.N. Ono, K.M. Lyons, et al. 2008. A new model for growth factor activation: type II receptors compete with the prodomain for BMP-7. J. Mol. Biol. 381: 1025-1039.
16. Katagiri,T.,T. Suda& K.Miyazono. 2008. TheBoneMorphogenetic Proteins. In The TGF-β Family. Derynck, R. & K.Miyazono, Eds.: 121-149. Cold SpringHarbor Laboratory Press. Cold Spring Harbor, NY.
17. Rifkin, D.B. 2005. Latent transforming growth factor-β (TGF-β) binding proteins: orchestrators of TGF-β availability. J. Biol. Chem. 280: 7409-7412.
18. Dallas, S.L., K. Miyazono, T.M. Skerry, et al. 1995. Dual role for the latent transforming growth factor-- binding protein in storage of latent TGF-β in the extracellular matrix and as a structural matrix protein. J. Cell Biol. 131: 539-549.
19. Dallas, S.L., D.R. Keene, S.P. Bruder, et al. 2000. Role of the latent transforming growth factor- binding protein 1 in fibrillin-containing microfibrils in bone cells in vitro and in vivo. J. Bone Miner. Res. 15: 68-81.
20. Isogai, Z., R.N. Ono, S. Ushiro, et al. 2003. Latent transforming growth factorβ-binding protein 1 interactswith fibrillin and is a microfibril-associated protein. J. Biol. Chem. 278: 2750-2757.
21. Neptune,E.R., P.A. Frischmeyer, D.E. Arking, et al. 2003. Dysregulation of TGF-β activation contributes to pathogenesis inMarfan syndrome. Nat. Genet. 33: 407-411.
22. Ng, C.M., A. Cheng, L.A Myers, et al. 2004. TGF-β activation contributes to pathogenesis of mitral valve prolapsed in a mouse model of Marfan syndrome. J. Clin. Invest. 114: 1586-1592.
23. Habashi, J.P., D.P. Judge, T.M. Holm, et al. 2006. Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome. Science 312: 117-121.
24. Cohn, R.D., C. van Erp, J.P. Habashi, et al. 2007. Angiotensin II Type 1 receptor blockade prevents TGFβ- induced failure of muscle regeneration in multiple myopathic states. Nature Med. 13: 204-210.
25. Carta, L., S. Smaldone, L. Zilberberg, et al. 2009. p38 MAPK is an early determinant of promiscuous Smad2/3 signaling in the aortas of fibrillin-1 (Fbn1)-null mice. J. Biol. Chem. 284: 5630-5636.
26. Ramirez, F. & E. Arteaga-Solis. 2008. Marfan syndrome and related disorders. In Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism. 7th edn. Rosen, C., Ed.: 450-454. ASBMR Publications,Washington, D.C.
27. Jones, K.B., P.D. Sponseller, G. Erkula, et al. 2007. Symposium of the musculoskeletal of Marfan syndrome: meeting report and state of the science. J. Orthop. Res. 25: 413-422.
28. Mundy, G.R., G. Boyce, D. Hughes, et al. 1995. The effects of cytokines and growth factors on osteoblastic cells. Bone 17: 71S-75S.